Valion Bio, Inc. Increase (Decrease) in Other Operating Assets
Valion Bio, Inc. (VBIO) reported Increase (Decrease) in Other Operating Assets of $90.00 thousand for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-08-14.
Financial Statements › Cash Flow › Operating Activities
us-gaap:IncreaseDecreaseInOtherOperatingAssets · last filed 2026-08-14
- Valion Bio, Inc. increase (decrease) in other operating assets for the quarter ending 2026-06-30 was $4.00K.
- Valion Bio, Inc. increase (decrease) in other operating assets for the quarter ending 2026-03-31 was $86.00K, a 4200.00% increase year-over-year.
- Valion Bio, Inc. increase (decrease) in other operating assets for the quarter ending 2025-12-31 was -$23.00K.
- Valion Bio, Inc. increase (decrease) in other operating assets for the quarter ending 2025-09-30 was $21.00K.
- Valion Bio, Inc. increase (decrease) in other operating assets for fiscal 2025 was $0.00.
- Valion Bio, Inc. increase (decrease) in other operating assets for fiscal 2024 was -$34.00K.
- Valion Bio, Inc. increase (decrease) in other operating assets for fiscal 2022 was -$15.00K.
| Period end | Increase (Decrease) in Other Operating Assets 3 month | Increase (Decrease) in Other Operating Assets 6 month | Increase (Decrease) in Other Operating Assets 9 month | Increase (Decrease) in Other Operating Assets 12 month |
|---|---|---|---|---|
| 2026-06-30 | $4.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-14 | $90.00K 10-Q · filed 2026-08-14 | $67.00K derived: sum of 3 quarters · filed 2026-08-14 | $88.00K derived: sum of 4 quarters · filed 2026-08-14 |
| 2026-03-31 | $86.00K 10-Q · filed 2026-05-14 | $63.00K derived: sum of 2 quarters · filed 2026-05-14 | $84.00K derived: sum of 3 quarters · filed 2026-05-14 | $84.00K derived: sum of 4 quarters · filed 2026-08-14 |
| 2025-12-31 | -$23.00K derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-30 | -$2.00K derived: sum of 2 quarters · filed 2026-03-30 | -$2.00K derived: sum of 3 quarters · filed 2026-08-14 | $0.00 10-K · filed 2026-03-30 |
| 2025-09-30 | $21.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-14 | $21.00K derived: sum of 2 quarters · filed 2026-08-14 | $23.00K 10-Q · filed 2025-11-14 | $23.00K derived: sum of 4 quarters · filed 2026-08-14 |
| 2025-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-14 | $2.00K 10-Q · filed 2026-08-14 | $2.00K derived: sum of 3 quarters · filed 2026-08-14 | |
| 2025-03-31 | $2.00K 10-Q · filed 2026-05-14 | $2.00K derived: sum of 2 quarters · filed 2026-05-14 | ||
| 2024-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-30 | -$34.00K 10-K · filed 2026-03-30 | ||
| 2024-09-30 | -$34.00K 10-Q · filed 2025-11-14 | |||
| 2022-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2024-03-25 | $0.00 derived: sum of 2 quarters · filed 2024-03-25 | -$15.00K 10-K · filed 2024-03-25 | |
| 2022-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-14 | -$15.00K 10-Q · filed 2022-11-14 | ||
| 2022-06-30 | -$15.00K 10-Q · filed 2022-08-15 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| MAIA Biotechnology, Inc. (MAIA) | United States | $0.077B | -2.30 |
| iBio, Inc. (IBIO) | United States | $0.077B | -2.94 |
| Adicet Bio, Inc. (ACET) | United States | $0.078B | -0.81 |
| Lifevantage Corp (LFVN) | United States | $0.078B | 15.40 |
| Verrica Pharmaceuticals Inc. (VRCA) | United States | $0.076B | -3.39 |
| OS Therapies Inc (OSTX) | United States | $0.076B | -2.17 |
| Gain Therapeutics, Inc. (GANX) | United States | $0.080B | -4.40 |
| Aldeyra Therapeutics, Inc. (ALDX) | United States | $0.074B | -5.57 |
| Cingulate Inc. (CING) | United States | $0.073B | -2.64 |
| Spero Therapeutics, Inc. (SPRO) | United States | $0.073B | 17.41 |